D07.39 — Carcinoma in situ of other female genital organs
D07.39 is a billable, specific ICD-10-CM code for carcinoma in situ of other female genital organs. It is valid for submission on a claim.
Other codes that can never be billed with D07.39
These codes carry an Excludes1 note pointing at D07.39. The conflict binds both ways, but ICD-10-CM only writes it down on one side — so you would not find this by reading D07.39 alone.
- D09.3Carcinoma in situ of thyroid and other endocrine glands
Risk adjustment
D07.39 does not map to an HCC and does not risk-adjust under CMS-HCC V28. That is normal — most ICD-10 codes do not. It still needs to be coded correctly; it just will not move a RAF score.
Medicare coverage
D07.39 is named in 20 Medicare coverage policies — 20 listing it as supporting medical necessity. Which of them applies to you depends on your Medicare contractor, and coverage genuinely differs by state.
- A52480Oral Antiemetic Drugs (Replacement for Intravenous Antiemetics) - Policy Article
- A53883Billing and Coding: Mohs Micrographic Surgery (MMS)
- A54768Billing and Coding: Cardiac Blood Pool Imaging (Multiple Gated Acquisition Scanning- MUGA, Ventriculography) When Performed in Conjunction with Cardiotoxic Chemotherapy
- A56421Billing and Coding: CT of the Abdomen and Pelvis
Related codes at this level
Codes that share D07.3. If D07.39 is not quite right, the correct code is usually one of these.
Questions about D07.39
- Is D07.39 a billable ICD-10-CM code?
- Yes. D07.39 is a billable, specific ICD-10-CM code and is valid for submission on a claim.
- Where does D07.39 sit in the tabular list?
- Neoplasms (C00-D49), in the block In situ neoplasms (D00-D09).